GYRE EPS Estimates
Gyre Therapeutics, Inc.
$6.53
+$0.06(+0.93%)
40
Overall
40
Value
36
Tech
44
Quality
Market Cap
$721.47M
Volume
2.77K
52W Range
$5.44 - $9.42
Target Price
$18.67
GYRE EPS estimates: the consensus estimate for Gyre Therapeutics, Inc.'s current fiscal year is -$0.61 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
GYRE EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.16
- EPS estimate, current year
- $-0.61
- EPS estimate, next year
- $-0.47
- EPS growth, 3-year
- +26.31%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.06 |
| 2024 | $0.14 |
| 2023 | $-1.41 |
| 2022 | $-3.90 |
| 2021 | $-43.05 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GYRE | $6.53 | +0.9% | 2.77K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |